$LUCD Income Statement | Understand Stock

$LUCD

$0.44 -$0.06 (12.5%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Operating expenses:
Cost of revenue
Sales and marketing
General and administrative
Amortization of acquired intangible assets
Research and development

Total operating expenses
Total operating expenses
Operating loss
Interest expense - Senior Unsecured Promissory Note
Interest income
Interest expense
Change in fair value - Senior Secured Convertible Note
Loss on issue and offering costs - Senior Secured Convertible Note
Other income (expense):
Interest income
Interest expense
Change in fair value - Senior Secured Convertible Note
Debt extinguishments loss - Senior Secured Convertible Note
Equity issuance cost extinguishment
Other income (expense), net
Loss before provision for income tax
Provision for income taxes
Net loss attributable to Lucid Diagnostics Inc.
Net loss per share - basic and diluted
Weighted average common shares outstanding, basic and diluted
Dividends
Series A and A-1 Preferred Stock
Series B and B-1 Preferred Stock
Total dividends
Net loss attributable to Lucid Diagnostics Inc. common stockholders
Net loss per share attributable to Lucid Diagnostics Inc. common stockholders - basic and diluted (in dollars per share)
Weighted average common shares outstanding, basic and diluted (in shares)

Comments